Library Header Image
LSE Research Online LSE Library Services

Competition in prescription drug markets: is parallel trade the answer?

Kanavos, Panos ORCID: 0000-0001-9518-3089 and Vandoros, Sotiris (2010) Competition in prescription drug markets: is parallel trade the answer? Managerial and Decision Economics, 31 (5). pp. 325-338. ISSN 0143-6570

Full text not available from this repository.
Identification Number: 10.1002/mde.1486


This article uses a price determination model with dynamic panel data estimation to examine the extent to which pharmaceutical parallel trade promotes price competition and leads to downward price convergence. Little evidence of sustainable price competition is found. We find that prices are mainly affected by regulation and by competition in the wholesale distribution chain; that the pricing strategy of parallel distributors resembles that of originator drugs in importing countries; and that there may be upward rather than downward price convergence. Drawing on the European evidence, the findings also indicate that opening the US market to parallel imports will not necessarily lead to competition and enhance pharmaceutical cost containment.

Item Type: Article
Official URL:
Additional Information: © 2010 John Wiley & Sons, Ltd.
Divisions: Social Policy
LSE Health
Subjects: H Social Sciences > HF Commerce
R Medicine > RA Public aspects of medicine
Date Deposited: 04 Jan 2011 11:45
Last Modified: 20 Oct 2021 01:49

Actions (login required)

View Item View Item